These results indicate that only in HCC patients with MMP14 expression in tumor, the low level of ACADL is a predictive marker for poor outcome, further supporting an important role of MMP14 in ACADL-induced HCC metastasis. This evidence concerns the gene MMP14 and neoplasm.